Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nancy Foldvary-Schaefer, DO, FAAN. [LISTEN TIME: 25 minutes]
Episode 139 of the NeurologyLive®
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
In this episode, "Sleep and Seizures: Emerging Insights from AAN 2025," Nancy Foldvary-Schaefer, DO, director of the Sleep Disorders Center at
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
FDA Approves Pre-Filled Syringe Administration for FcRn Modulator Efgartigimod FDA Approves CT-132 as First Digital Therapeutic for Preventive Treatment of Episodic Migraine FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5
EPISODE BREAKDOWN
- 1:00 – Key sleep topics discussed at AAN 2025 and the growing interest in hypersomnia
- 5:45 – Development and purpose of the SLEEP mobile app by Cleveland Clinic
- 10:35 – Findings on obstructive sleep apnea prevalence in adults with epilepsy
- 15:05 – Neurology News Minute
- 17:10 – The need for sleep disorder screening in epilepsy clinical trials
- 19:45 – Exploratory findings on SSRI use and respiratory patterns in patients with epilepsy
Hoping to listen on your favorite podcast app? See below:
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.